Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

CarrerasPathfinders · Enabling the next generation in search of blood cancer cures

HORIZONStatus: SIGNED1 September 202431 August 2029EU funding €1,881,600Call HORIZON-MSCA-2022-COFUND-01

The CarrerasPathfinder program is new a world-wide unique doctoral program that covers the entire spectrum of research and innovation in blood cancers from understanding disease biology to the implementation of novel processes in the clinical practice. The program will fund 14 excellent Doctoral Candidates (DCs) for a period of 48 months. DCs will perform collaborative PhD projects involving associated partners from different sectors, countries, and disciplines through secondments. DCs will improve their research capacity and transferable skills through high-quality supervision arrangements and a tailored training program.The program has been designed and will be hosted by the Josep Carreras Leukaemia Research Institute (IJC) which is the first European non-profit institute exclusively devoted to blood cancers. By answering the European needs for human resources, it is fully aligned with the 13 recommendations of the EU Cancer Board’s Draft Mission and the Europe’s Beating Cancer Plan (2021). The CarrerasPathfinder program has a strong triple-I dimension of internationality, inter-sectorality and interdisciplinarity in training, networking, co-supervision and research. Its specific objectives are:•To develop an excellent doctoral program in blood cancer research conceived as a pilot for a permanent international doctoral program•To equip DCs with a unique skill set boosting effectiveness and innovation capacity. •To promote DCs’ career development and increase their employability in different sectors.•To establish the IJC as a European reference for research and training in blood cancers.•To provide Europe with a new generation of researchers able to address unmet needs and societal challenges of blood cancers.•To contribute to structuring the European research area by collaborating and synergizing with other European key opinion leaders.

Consortium · 47 organisations

coordinator

FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

ES · €1,881,600

associatedPartner

UNIVERSITY OF SHARJAH

AE

associatedPartner

APPLIED NANOPARTICLES SL

ES

associatedPartner

CONSORCIO PARA LA CONSTRUCCION EQUIPAMIENTO Y EXPLOTACION DEL LABORATORIO DE LUZ SINCROTRON

ES

associatedPartner

Fundació Internacional Josep Carreras

ES

associatedPartner

ASOCIACION INNOLIFE SPAIN

ES

associatedPartner

FUNDACION PARA EL CONOCIMIENTO MADRIMASD

ES

associatedPartner

FUNDACIO INSTITUCIO DELS CENTRES DE RECERCA DE CATALUNYA

ES

associatedPartner

USTAV MOLEKULARNI GENETIKY AV CR V.V.I.

CZ

associatedPartner

ANAXOMICS BIOTECH SL

ES

associatedPartner

UNIVERSITY OF NEWCASTLE UPON TYNE

UK

associatedPartner

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

DE

associatedPartner

UNIVERSITA DEGLI STUDI DI TORINO

IT

associatedPartner

Specialized Hospital for Active Treatment of Hematological Diseases

BG

associatedPartner

FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE

PT

associatedPartner

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

CH

associatedPartner

UNIVERSITE LIBRE DE BRUXELLES

BE

associatedPartner

EUROPEAN HEMATOLOGY ASSOCIATION

NL

associatedPartner

APPLIED RESEARCH USING OMIC SCIENCES SL

ES

associatedPartner

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

ES

associatedPartner

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

US

associatedPartner

NEW YORK UNIVERSITY

US

associatedPartner

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)

ES

associatedPartner

Gavin Lucas

ES

associatedPartner

UNIVERSITAT DE BARCELONA

ES

associatedPartner

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

DE

associatedPartner

FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR)

CH

associatedPartner

MESOESTETIC PHARMA GROUP S.L.

ES

associatedPartner

HUMANITAS MIRASOLE SPA

IT

associatedPartner

Asociación Española Contra el Cáncer

ES

associatedPartner

UNIVERSITETET I OSLO

NO

associatedPartner

SCIENSEED SL

ES

associatedPartner

SEMMELWEIS EGYETEM

HU

associatedPartner

ONKOLOSKI INSTITUT LJUBLJANA

SI

associatedPartner

QUIMATRYX SL

ES

associatedPartner

FUNDACION CIENTIFICA DE LA ASOCIACIÓN ESPANOLA CONTRA EL CANCER

ES

associatedPartner

INSTITUTUL NATIONAL DE CERCETARE - DEZVOLTARE IN DOMENIUL PATOLOGIEI SI STIINTELOR BIOMEDICALE VICTOR BABES RA

RO

associatedPartner

International Society for Experimental Hematology

US

associatedPartner

BIOCAT LA FUNDACIO BIOREGIO DE CATALUNYA

ES

associatedPartner

UNIVERSITAT AUTONOMA DE BARCELONA

ES

associatedPartner

ONECHAIN IMMUNOTHERAPEUTICS S.L.

ES

associatedPartner

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

DE

associatedPartner

BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIA

SK

associatedPartner

UNIVERSITY OF CYPRUS

CY

associatedPartner

NOVOGENE UK COMPANY LIMITED

UK

associatedPartner

MLL MUNCHNER LEUKAMIELABOR GMBH

DE

associatedPartner

BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION

ES

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.